Stewart Appelrouth

CIK: 0001702626

Transaction Breakdown

Open Market Buys (P)3 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AIM

AIM ImmunoTech Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

AIM
AIM ImmunoTech Inc.
Dec 31, 2024
Award(A)
Direct
8.8K shares at avg. $0.20$2K
AIM
AIM ImmunoTech Inc.
Dec 13, 2024
Award(A)
Direct
24.5K shares at avg. $0.21$5K
AIM
AIM ImmunoTech Inc.
Dec 2, 2024
Purchase(P)
Direct
1 shares at avg. $0.21$0.212
AIM
AIM ImmunoTech Inc.
Dec 2, 2024
Purchase(P)
Direct
11.1K shares at avg. $0.21$2K
AIM
AIM ImmunoTech Inc.
Dec 2, 2024
Award(A)
Direct
22.6K shares at avg. $0.23$5K
AIM
AIM ImmunoTech Inc.
Nov 20, 2024
Purchase(P)
Direct
82K shares at avg. $0.19$16K

		Type	Shares	Price		Ownership
Dec 31, 2024	AIM AIM ImmunoTech Inc.	Award(A)	8,768	$0.20	$1,736	Direct
Dec 13, 2024	AIM AIM ImmunoTech Inc.	Award(A)	24,452	$0.21	$5,208	Direct
Dec 2, 2024	AIM AIM ImmunoTech Inc.	Purchase(P)	1	$0.21	$0	Direct
Dec 2, 2024	AIM AIM ImmunoTech Inc.	Purchase(P)	11,111	$0.21	$2,356	Direct
Dec 2, 2024	AIM AIM ImmunoTech Inc.	Award(A)	22,645	$0.23	$5,208	Direct
Nov 20, 2024	AIM AIM ImmunoTech Inc.	Purchase(P)	81,953	$0.19	$15,817	Direct

1-6 of 6 transactions

About APPELROUTH STEWART

APPELROUTH STEWART (SEC CIK 0001702626) files insider reports with the SEC as Director of AIM ImmunoTech Inc. (AIM).

Signal8 holds 5 ownership filings by APPELROUTH STEWART, all Form 4s, filed between Nov 21, 2024 and Jan 3, 2025. Those filings report 6 transactions, from Nov 20, 2024 to Dec 31, 2024. Signal8's Form 4 history starts in Sep 2024.

The business address on APPELROUTH STEWART's filings is in OCALA,, FL.

Recent filings by APPELROUTH STEWART

Dec 31, 2024: Grant or award of AIM shares (Form 4, code A).
Dec 13, 2024: Grant or award of AIM shares (Form 4, code A).
Dec 2, 2024: Open-market purchases of AIM shares (2 lines, Form 4, code P).
Dec 2, 2024: Grant or award of AIM shares (Form 4, code A).
Nov 20, 2024: Open-market purchase of AIM shares (Form 4, code P).

Other insiders filing for AIM ImmunoTech Inc. (AIM)

Equels Thomas K, CEO & President
CHEMEROW DAVID I., Director
KELLNER TED D, Director
MITCHELL WILLIAM M, Director
Rodino Peter W III, COO, Secretary, Gen. Counsel
BRYAN NANCY, Director

How to read Form 4 transaction codes